Vectra® Study Published in the Journal Current Medical Research & Opinion
Go back to Vectra® Study Published in the Journal Current Medical Research & Opinion| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 3.05 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $45.34 | |||
| Open | $3.05 | 52 Week Low | $15.92 | |||
| Day High | $3.05 | P/E | 1.31 | |||
| Day Low | $3.05 | EPS | $2.33 | |||
| Volume | 375 | |||||
